Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 33
Phase 41

Trial Status

Completed2
Terminated1
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT01558115Phase 4Terminated
Denosumab in Primary Hyperparathyroidism
Primary Hyperparathyroidism
PrincipalinvestigatorStart date: 2012-01-01
NCT01199614Phase 3Completed
HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism
Hypoparathyroidism
PrincipalinvestigatorStart date: 2009-12-01
NCT00473265Phase 2/3Completed
Bone Properties in Hypoparathyroidism: Effects of PTH
Hypoparathyroidism
Principalinvestigator
NCT00856401Phase 3Unknown
ADD-ON Study to Existing Hypoparathyroidism Studies
Hypoparathyroidism
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Columbia University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Theodora Stratigou, M.D

Department of Endocrinology and First Department of Internal Medicine, 'Evangelismos' General Hospital of Athens, Athens, Greece.

Related
1 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Mishaela Rubin, MD

Columbia University

Related
3 trials

Shared therapeutic areas:

Hypoparathyroidism

Worked with same sponsors:

Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score15%

Eva Kassi, M.D

Medical School, National and Kapodistrian University of Athens, LAIKO University Hospital of Athens

Related
1 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Fotini Adamidou, M.D

Department of Endocrinology and Diabetes, Hippokratio General Hospital, Thessaloniki, Greece.

Related
1 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Rafael Luboshitzky, MD

Endocrine Institute, Haemek Medical Center, Afula, Israel

Related
2 trials

Shared therapeutic areas:

Hyperparathyroidism, Primary
Similarity Score15%

Dimos Florakis, M.D.

Department of Endocrinology, Metropolitan General Hospital, Athens, Greece.

Related
1 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Nancy D. Perrier, MD

M.D. Anderson Cancer Center

Related
11 trials

Shared therapeutic areas:

Hyperparathyroidism, Primary
Similarity Score15%

Bettina Mittendorfer, PhD

University of Missouri-Columbia

Related
4 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Symeon Tournis, M.D

Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital, 10 Athinas Str, Kifissia, Athens,

Related
1 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Mette Rosenkilde, MD

University of Copenhagen

Related
3 trials

Shared therapeutic areas:

Hypoparathyroidism
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT01558115Phase 4PrincipalInvestigator

Denosumab in Primary Hyperparathyroidism

Primary Hyperparathyroidism
Terminated
NCT01199614Phase 3PrincipalInvestigator

HEXT (Hypo EXTended): Effect of PTH on Skeleton in Hypoparathyroidism

Hypoparathyroidism
Completed
NCT00473265Phase 2/3PrincipalInvestigator

Bone Properties in Hypoparathyroidism: Effects of PTH

Hypoparathyroidism
Completed
NCT00856401Phase 3PrincipalInvestigator

ADD-ON Study to Existing Hypoparathyroidism Studies

Hypoparathyroidism
Unknown

All 4 trials loaded